| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CEO | President And CEO
1 company
Bohen Sean is a President And CEO at Olema Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 12 sells.
Estimated insider holdings value: $3.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 11, 2024 | OLMA Olema Pharmaceuticals, Inc. | President And CEO | Sell | 109,502 | $9.01 | $986,365.11 | -12.3% | -48.5% | +275.5% | |
| Nov 22, 2023 | OLMA Olema Pharmaceuticals, Inc. | President And CEO | Sell | 57,225 | $14.40 | $824,133.82 | -10.4% | +4.3% | -42.8% | |
| Oct 14, 2021 | OLMA Olema Pharmaceuticals, Inc. | President And CEO | Sale+OE | 5,000 | $30.47 | $152,363.25 | -4.5% | -77.5% | -90.6% | |
| Sep 27, 2021 | OLMA Olema Pharmaceuticals, Inc. | President And CEO | Sale+OE | 1,085 | $30.07 | $32,625.95 | -2.0% | -68.0% | -90.6% | |
| Sep 8, 2021 | OLMA Olema Pharmaceuticals, Inc. | President And CEO | Sale+OE | 3,044 | $30.01 | $91,353.04 | -2.8% | -62.9% | -85.2% | |
| Sep 1, 2021 | OLMA Olema Pharmaceuticals, Inc. | President And CEO | Sale+OE | 871 | $30.05 | $26,173.55 | -1.6% | -70.4% | -87.5% |